A Study on Assessment of Risk Factor, Management and Health Related Quality of Life in Cld Patients

Chronic liver disease (CLD) is a global health concern characterized by persistent liver dysfunction, leading to fibrosis and cirrhosis. This nine-month prospective observational study aimed to assess the risk factors, management, and health-related quality of life (HRQoL) in CLD patients. Conducted at St. Philomena’s Hospital, the study included 102 patients, aged 18 and above, with confirmed CLD diagnoses. Demographic, social, and medical data were collected, and HRQoL was assessed using the SF-36 questionnaire. The majority of patients were male (76.47%), aged 51-60 years (37.25%), with a significant history of alcohol consumption and comorbidities such as diabetes. Clinical manifestations like edema were common, and liver damage was indicated by abnormal liver function tests. Most patients received diuretics, hepatoprotective agents, and nutritional supplements. SF- 36 results revealed that most patients had a poor quality of life, highlighting the significant impact of CLD on daily functioning. This study underscores the need for effective disease management and improved patient outcomes.